13F Portfolios

Jones Hill Capital LP 13F: Portfolio & Holdings

In its most recent SEC Form 13F-HR filing (as of Q2 2026), Jones Hill Capital LP (SEC CIK 0002102314) reported 29 positions with a combined market value of $0.5 billion. The New York-based hedge fund has a Healthcare sector tilt, which represents 100.0% of its exposure.

Its largest holdings are Biomarin Pharmaceutical INC (BMRN) at 17.4%, Gilead Sciences INC (GILD) at 9.2%, and Arcutis Biotherapeutics INC (ARQT) at 6.1%.

The largest new position was Gilead Sciences INC (GILD) at 9.2% of the portfolio. See the fund’s full Q2 2026 buys, sells, and portfolio changes →

Based on published SEC 13F filings, Jones Hill's closest peer funds by portfolio overlap are Avidity Partners Management LP (41.4%), Paulson & CO. INC. (27.9%), and Deerfield Management Company, L.P. (27.9%).

13F AUM
$0.5B
Equity Positions
29
Top-10 Concentration
68.8%
Largest Sector · 100.0%
Healthcare
Longest-Held Position · 2 qtrs
AMLX
Median Holding Period
1 Qtrs

What are Jones Hill’s largest 13F holdings as of Q2 2026?

Largest 13F positions disclosed by Jones Hill, ranked by portfolio weight. Full multi-quarter history and the broader institutional holder base for each ticker linked per row.

Top 10 disclosed equity positions for Jones Hill in Q2 2026, ranked by portfolio weight. Share count and market value sourced from SEC Form 13F-HR filings.
# Issuer Ticker Sector Weight Position Value Detail
1 BIOMARIN PHARMACEUTICAL INC BMRN Healthcare 17.4% $81.9M Position History All Holders
2 GILEAD SCIENCES INC NEW GILD Healthcare 9.2% $43.3M Position History All Holders
3 ARCUTIS BIOTHERAPEUTICS INC NEW ARQT Healthcare 6.1% $28.6M Position History All Holders
4 MADRIGAL PHARMACEUTICALS INC NEW MDGL Healthcare 6.0% $28.2M Position History All Holders
5 BICARA THERAPEUTICS INC BCAX Healthcare 5.6% $26.5M Position History All Holders
6 RELMADA THERAPEUTICS INC RLMD Healthcare 5.4% $25.3M Position History All Holders
7 TREVI THERAPEUTICS INC TRVI Healthcare 5.3% $25.0M Position History All Holders
8 PHARVARIS N V PHVS Healthcare 5.0% $23.4M Position History All Holders
9 XENON PHARMACEUTICALS INC NEW XENE Healthcare 4.7% $22.2M Position History All Holders
10 ANI PHARMACEUTICALS INC ANIP Healthcare 4.1% $19.4M Position History All Holders

View Jones Hill's Q2 2026 portfolio changes and trading report →

Latest

Portfolio composition

Sectors, concentrations, and a tap-through treemap of every position in the fund's latest 13F.

Allocation by stock29 positions · click any tile for institutional holders
Allocation by sector1 sectors · same palette as the stock tiles

Holding period analytics

Distribution of holding periods for all 41 stocks the fund has ever held (up to selected quarter):

Which Funds Hold a Similar Portfolio to Jones Hill?

Ranked by percentage of the peer fund's 13F equity portfolio that overlaps with Jones Hill's positions in Q2 2026.

Funds with the most portfolio overlap with Jones Hill in Q2 2026, ranked by overlap percentage
# Fund Shared Positions Overlap %
1 Avidity Partners Management LP 8 41.4%
2 Paulson & CO. INC. 1 27.9%
3 Deerfield Management Company, L.P. 7 27.9%
4 Tri Locum Partners LP 4 23.7%
5 Fairmount Funds Management LLC 2 22.6%
6 Saturn V Capital Management LP 4 22.4%
7 Trails Edge Capital Partners, LP 5 22.0%
8 Vestal Point Capital, LP 9 21.7%
9 Octagon Capital Advisors LP 4 21.2%
10 Commodore Capital LP 5 20.2%

How Has Jones Hill's AUM Changed Over Time?

Quarterly 13F-reported AUM for Jones Hill, derived from aggregate reported position market values disclosed to the U.S. SEC.

Methodology & FAQ

How We Track Jones Hill Holdings

Our data is systematically aggregated directly from quarterly Form 13F-HR disclosures submitted to the U.S. Securities and Exchange Commission (SEC).

  • Who must file: This dataset includes filings from U.S. institutional investment managers, hedge funds, mutual funds, university endowments, and family offices managing at least $100 million in Section 13(f) securities (including equities, options, convertibles, ETFs, and warrants).
  • What is included: By regulation, 13F filings include long positions in U.S. exchange-listed stocks, ETFs, shares of closed-end investment companies, and convertible debt, as defined in the SEC's official Section 13(f) securities list . For listed options (calls/puts) the reported value is based on the notional value.
  • Metric definition: “Portfolio Weight” shows how much of a fund's total reported 13F portfolio value (excluding listed options) is allocated to a specific position on the reporting date.
  • How to use this data: Quarter-over-quarter changes in shares and portfolio weight reflect a combination of active trading and market price movements. These are descriptive metrics of fund allocation, not explicit buy or sell signals.
What does Jones Hill's 13F filing disclose about their portfolio?

A Form 13F-HR filed by Jones Hill with the U.S. SEC discloses all long positions in Section 13(f) securities (U.S.-listed equities, ETFs, closed-end funds, and listed put/call options) held at quarter-end with a market value of at least $200,000 or 10,000 or more shares. Pactolio aggregates these filings to surface the manager’s reported portfolio weights, share counts, and quarter-over-quarter portfolio changes in a structured format. The filing represents a point-in-time snapshot of disclosed long-side exposure, not a real-time or complete view of the fund’s total book.

How do you measure conviction in Jones Hill's portfolio allocations?

Conviction is measured by portfolio weight, the percentage of Jones Hill’s total reported 13F market value allocated to a given position, rather than by absolute share count or dollar value alone. A position representing a disproportionately large share of the fund’s disclosed book signals high-conviction allocation, regardless of whether it ranks among the fund’s largest absolute holdings.

What is excluded from Jones Hill's 13F: short positions, swaps, and derivatives?

SEC Form 13F requires disclosure of long positions only. Specifically excluded are: short interest, total return swaps, credit default swaps, and all OTC derivatives, none of which appear in 13F filings regardless of position size. Listed put and call options must be disclosed but are excluded from portfolio weight calculations on this platform so that reported weights reflect direct equity exposure and remain comparable across filers. This means Jones Hill’s 13F represents the reported long book, which may differ materially from its net economic exposure.

When is Jones Hill's 13F data available, and how large is the reporting lag?

Investment managers must submit Form 13F within 45 calendar days of each quarter-end (the T+45 deadline). Pactolio ingests filings directly from SEC EDGAR as they are published, so managers who file early appear in our system before the deadline, while late filers are captured on their actual filing date. The quarter label shown at the top of this page reflects the most recently processed 13F cycle for Jones Hill. The inherent reporting lag means the data always reflects positions as of the prior quarter-end, not current holdings.

Who must file a Form 13F with the SEC, and does Jones Hill qualify?

Under SEC Rule 13f-1, any investment manager (including hedge funds, family offices, registered investment advisers, pension funds, and university endowments) that exercises investment discretion over $100 million or more in Section 13(f) securities at any point during a calendar year must file Form 13F for that year. Jones Hill meets this threshold, which is why its holdings are publicly disclosed and accessible on this platform. The $100 million threshold is evaluated on a rolling basis, meaning new filers can enter and existing filers can exit the disclosure regime as AUM crosses that boundary.